VaramirStart free · no cardSign in
MRVI as of Nov 1 · 01:01 ET
MRVINasdaqPharmaceutical Preparations

Maravai Lifesciences Holdings, Inc. · Brief

Next report

4 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±26.1%
avg realized
±11.7%
Jan 8 '25±22.4%▼−20.88%×0.93
Mar 18 '25±14.7%▼−5.81%×0.39
May 12 '25±22.5%▼−2.83%×0.13
Aug 11 '25±41.4%▲+30.58%×0.74
Q3 FY25±25.4%▼−0.69%×0.03
Q1 FY26±26.3%▲+9.20%×0.35
May 7 '26±29.0%▲+23.10%×0.80
Q2 FY26±27.5%▼−0.32%×0.01
quarterimplied−45%0+45%realized×
Q2 FY26±27.5%▼−0.32%×0.01
May '26±29.0%▲+23.10%×0.80
Q1 FY26±26.3%▲+9.20%×0.35
Q3 FY25±25.4%▼−0.69%×0.03
Aug '25±41.4%▲+30.58%×0.74
May '25±22.5%▼−2.83%×0.13
2 older reports
Mar '25±14.7%▼−5.81%×0.39
Jan '25±22.4%▼−20.88%×0.93
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull1

178managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

3tracked funds holding MRVIN-PORT · Aug 31 '26
7 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

MRVI report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±26.6% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.